ArticleJournal of nanobiotechnology2021

Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19.

Tianchuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.